Guest guest Posted February 21, 2008 Report Share Posted February 21, 2008 http://integratedneurology.net/cmt.htm Charcot-Marie-Tooth Disease (scroll down for vitamins, supplements information) bio on Dr. Kurn at http://integratedneurology.net/sdney_kurn_MD.htm Described in 1886 by two French professors Jean-Martn Charcot and his student Pierre Marie and later by Dr. Tooth of London. Also called peroneal muscular atrophy because of early involvement of the peroneal muscle that dorsiflexes the foot. For a time, a classification system by Dyck and Lambert (the hereditary motor and sensory neuropathies – HMSN) was used to classify the different hereditary neuropathies. Identification of genetic causes for an increasing number of neuropathies has made this system less useful. In general, CMT1, affecting approximately 80% of CMT patients, is a demyelinating form and CMT2 (affecting at least 20% of CMT patients) is neuronal, involving the nerve fiber rather than the myelin coating. Both types are autosomal dominant. CMT is fairly common affecting 36 out of every 100,000 individuals in the United States. CMT is now known to have multiple genetic causes. During the last decade, 18 genes and 11 additional loci harboring candidate genes have been associated with Charcot-Marie-Tooth disease (CMT) and related peripheral neuropathies. CMT 1A Autosomal dominant with duplication of a 1.5 Mb (megabase = 1 million nucleotides) region on the short arm of Chromosome 17(p11.2- p12) containing the PMP22(peripheral myelin protein 22) gene. This occurs in 70-90% of patients with clinical disease Point mutation in PMP22 gene CMT1B CMT 1B is rare and is associated with point mutations in the myelin protein zero(MP0 or MPZ) gene. MPZ is a major protein of compact peripheral nervous system myelin. Hereditary neuropathy with Deletion on chromosome 17 Liability to pressure palsy (HNPP) (same region as duplication in CMT1A) CMTX X linked dominant(CMTX1) and X-linked recessive(CMTX2) forms of CMT occur due to an abnormality in the connexin 32 gene at Xq13.1 This gene encodes a gap junction protein of peripheral myelin protein. CMT4B Point mutations of MTMR2 gene, encoding myotubularin-related Protein-2 CMT 2A Gene abnormality on chromosome 1 encoding for the mitofusion 2 (MFN2) protein that controls behavior of mitochondria. Large clusters are formed that fail to travel down the axon causing synapses to fail. CMT 2E Point mutations in neurofilament light (NF-L) gene Genetic testing is available for a number of different CMT types. It is also known that the pathologies of the different types overlap due to the close interaction of Schwann cells (that produce myelin) and the axons. There is evidence for abnormal communication between Schwann cells and axons in CMT. Clinical Features - CMT1 is associated with loss of reflexes, hypertrophy of nerves, and slow NCV measures. CMT2 has normal reflexes, no nerve enlargement and no or only mildly affected NCV studies. Both may have weakness, abnormalities of gait(steppage gait), foot deformities, loss of balance, pes cavus, hammer toes, leg atrophy, intrinsic hand muscle atrophy, leg cramps, functional loss of use of hands, hand tremors, stocking pin prick loss(rare) and vibratory loss. Medications can be used including antidepressants such as the tricyclics such as amitryptiline, desipramine or nortriptyline or newer antidepressants such as Remeron or Cymbalta. Anticonvulsants can be used including Neurontin or Lyrica. Mind – body techniques including meditation, using a mantra or focussing on one's breath; guided imagery placing oneself in tranquil settings and contacting " inner guides " ; deep breathing by inhaling deeply for 4 seconds then exhaling over 4 seconds(relaxing muscles and lowering blood pressure); progressive muscle relaxation using tension for 5 seconds followed by relaxation starting with your fists and moving to the rest of your muscle groups. Acupuncture; may help pain and improve functional level. Acupuncture increases the flow of chi, the life-force, by placing needles in points along lines called meridians that course over the body. Use of supplements to improve function and provide neuroprotection Creatine - Creatine is a nitrogenous organic acid that naturally occurs in vertebrates and helps to supply energy to muscle cells.It keeps the ATP/ADP ratio high which ensures that the free energy of ATP (the main energy molecule of the body) remains high and minimizes the loss of adenosine nucleotides (components of DNA), which would cause cellular dysfunction. Although the use of creatine in CMT has shown " mixed results " , the most recent study revealed changes in muscle fiber composition and improved strength in CMT patients when combined with resistance training (1,2). Dosage is 2-5 gms/day in three divided dosages. Co-enzyme Q10 - Coenzyme Q10(CoQ10) is a fat soluble quinone, created from tyrosine, occurring in the mitochondria of all cells. It is a cofactor in the electron transport chain that generates ATP. It also recycles vitamin E. It's level is reduced by HMG-CoA reductase inhibitors (such as Lipitor or Pravachol) and susceptibility to deficiency is greatest in the most metabolically active cells including the heart, gingiva, immune system and gastric mucosa. Inadequate nutritional intake, a genetic or acquired defect in synthesis, increased tissue needs or advancing age can lead to inadequate tissue levels. Several studies have shown a positive benefit of CoQ10 in neuromuscular disorders including CMT disease (3,4). Dosage should be at least 100mg/day (3,4). Vitamin C - Ascorbic acid is an organic acid with antioxidant properties. The L-enantiomer of ascorbic acid is also known as vitamin C. The name " ascorbic " comes from its property of preventing and curing scurvy. Ascorbate acts as an antioxidant by being itself available for energeticaly favourable oxidation. Studies reveal that vitamin C aids in proper myelin formation in peripheral nerves (5). A German study in 2006 showed that ascorbic acid reduced demyelination and premature death in a mouse model of CMT1A(6). An ongoing in Italy is studying the effect of 1500mg of vitamin C/day in CMT patients (7). 4. Padma - There is increasing evidence of an autoimmune component in CMT. There appears to be increased activation of cytotoxic lymphocytes as well as evidence for increased pro-inflammatory metabolites of arachidonic acid (8,9,10). A 2005 German study revealed macrophages (white blood cells who's role is to phagocytize (engulf and then digest) cellular debris and pathogens either as stationary or mobile cells, and to stimulate lymphocytes and other immune cells to respond to the pathogen) attacking myelin in a mouse model on CMT (11). This evidence suggest the use of an herbal compound such as Padma to quiet the immune activity in CMT. A number of countries, including Switzerland, Poland, Austria, Israel and the United States have studied Padma 28, an herbal mixture of 25 herbal constituents combined in a specific order with strict weight ratios. It is has been used for centuries in Tibetan medicine. Its efficacy in various disorders is related to modulation of immunological function. Several studies, including an Israeli study in 1995, suggest an anti-inflammatory effect. Padma inhibits lysozyme (a substance that breaks down tissue) release from stimulated human neutrophils and reduces nitric oxide production in macrophages. Nitric oxide is a small and pervasive molecule in the body that can be involved in inflammatory processes. Two of the constituents of Padma 28, costus root (the dried root of Saussurea chebula) and myrobalani fructus (the dried fruit of Terminalia chebula), by themselves inhibited nitric oxide production. A 1999 study in the US showed that Padma 28 had a dose-dependent effect against EAE in mice. The authors suggest that the protective effect could best be explained by a broad protective mechanism of action referred to as nonspecific resistance (NSR) to diverse biological and psychological stressors. The class of herbs or substances exhibiting these properties is called adaptogens or bioprotectants. A Polish study in 1982 showed improved suppressor cell function in T lymphocytes exposed to Padma 28.Suppressor cells are a subset of lymphocytes involved in inhibiting inflammatory reactions. The study revealed improved differentiation and maturation of the suppressor cell subset of T lymphocytes. Padma is safe and its properties suggest a beneficial effect in CMT. Dose is 2-3 tablets twice/day. 5. Essential fatty acids – the activation of arachidonic acid and the omega 6 metabolites of arachidonic acid suggest a benefit of supplementation with the anti-inflammatory omega three fatty acids. The most important omega three fatty acids, EPA and DHA, reduce a number of proinflammatory substances in the body including prostaglandin E2, and substances secreted by white blood cells including leukotriene B4 and other proinflammatory cytokines. In addition, EPA and DHA are precursors to the anti-inflammatory prostaglandin 3 series. DHA may be the most critical essential fatty acid for nerve cell membranes, including myelin, the coating around nerves. A 1986 study supplementing CMT patients with essential fatty acids and vitamin E revealed neurologic improvement which continued for a year after the placebo period ended (12). The author recommends that CMT patients supplement with heavy metal free fish oil. Dose is approximately 500mg EPA plus DHA twice/day. 6. Phosphatidylserine – A phospholipid that is an essential component in nerve cell membranes and myelin. It is a basic structural component and is also involved in signal transduction. DHA, discussed above is important as a metabolic precursor of phosphatidyl serine. There are a number of studies showing benefit of phosphatidylserine in cognition. Although there are no clinical studies in CMT, its importance in myelin and in information signaling suggests a potential benefit in CMT. 7. Vitamin E - Natural vitamin E is a fat soluble vitamin that exists in eight different forms or isomers, four tocopherols and four tocotrienols. It is an important anti-oxidant in the lipid or fat soluble compartments of the body. This includes the nervous system, a highly fatty tissue. Immune cells, such as the macrophages, decompose their targets with a highly pro-oxidant discharge of free radicals. As noted above, the immune system plays a role in myelin destruction in CMT. Vitamin E would provide a natural form of protection for myelin against free radical injury. An appropriate dosage is 400 IU/day. 8. Alpha lipoic acid - Alpha-lipoic acid is a very important antioxidant. It is both water and fat-soluble, enters the nervous system easily, reduces vitamins C and E from their oxidized state (making them reusable), and increases intracellular levels of glutathione, a critical intracellular antioxidant. Given the potential value of vitamin C and E in CMT, the addition of alpha lipoic acid is important in keeping C and E in their reduced or anti- oxidant form. Dosage for alpha-lipoic acid is 300mg/day of a sustained release formulation. 9. Vitamin B12 - The name vitamin B12 is used in two different ways. In a broad sense it refers to a group of cobalt-containing compounds known as cobalamins - cyanocobalamin (an artifact formed as a result of the use of cyanide in the purification procedures), hydroxocobalamin and the two coenzyme forms of B12, methylcobalamin (MeB12) and 5-deoxyadenosylcobalamin (adenosylcobalamin - AdoB12). It is know that B12 deficiency causes demyelination. The exact mechanism of B12's role in preserving myelin is not known. Due to its complete safety, and its role in the protection of myelin, B12 supplementation is recommended in CMT. Suggested dosage is 1 mg/day. 10. Although there are no studies confirming the efficacy of different herbs in CMT, their traditional usage suggest a potential tole in CMT. The following five herbs are presented here for their potential value in CMT: Ginkgo - Ginkgo biloba, also called maidenhair tree, is thought to predate the ice age, the sole remaining species of the entire ginkophyte botanical division flourishing 250 million years ago. The kernel has been used for several thousand years in Chinese medicine, while the leaf is a very recent addition to herbal medicine. Constituents include diterpenoid lactones-gingolide A,B,C; sesquiterpene - bilobalide, flavone glycosides - kaempferol, quercetin, isochamnetin; and tannins. There are more than 300 studies on ginkgo, including 40 clinical trials. Ginkgo has multiple pharmacologic effects including enhancing microcirculation, increasing blood fluidity, increasing tissue oxygen utilization, stabilizing blood-brain barrier and reducing cerebral edema, reducing platelet aggregation, antioxidant effect, and increasing dopaminergic, cholinergic and serotoninergic function. Experiments also show improved motor nerve regeneration. St. 's Wort - Hypericum perforatum is a perennial plant with bright yellow flowers. Hypericum, or " over an apparition " , makes reference to the historical use in exorcising ghosts, while perforatum refers to the tiny translucencies in the leaves that can be seen when holding the leaf to the sun. It's use dates back over the centuries to ancient Greece, with topical use for wounds and burns, and oral use for kidney and lung ailments as well as depression. The plant contains a red pigment, hypericin, along with essential oils, phenolic carboxylic acids, carotenoids, alkanes, phytosterols, phloroglucin derivatives, medium-chain fatty acids, flavonoids, xanthones and pseudohypericin. It has antimicrobial effects against multiple viruses including herpes simplex type 1 and 2, influenza type A and B, CMV, E-B virus, hepatitus B and retroviruses as well gram positive and negative bacteria. Originally conjectured to have clinical MAO inhibitory activity, the actual antidepressant mechanism is unknown. Its anti-depressant effect is well established. It is anti-inflammatory, and considered a vulnerary, or wound healer for the nervous system. Ashwaghanda – an adaptogen in Ayur Vedic medicine that promotes sleep, adaptation to stress, is anti-inflammatory and rejuvenating. It increased strength in a clinical trial in children. It is considered a nervine in Ayur Vedic medicine. Bacopa – the foremost nerve tonic in Ayur Vedic medicine. Reported to improve memory, learning and concentratrion. It improved motor efficiency in rat studies. Wild Oats – considered a nutritive herb for the nervous system. Exercise – See the diagram for the rocker/balance board that can strengthen ankles in CMT patients. Active and resistive exercises of the dorsiflexor, plantar flexor, pronater and supinater muscles of the feet. Use exercise puty for the intrinsic hand muscles and the finger flexors and extensors. Adjust program to the level of functioning and needs of the patient to maintain function and comfort, ensure safety and protect the joints. Do exercises daily. Can use hand splints and ADL aids. Do daily stretching of the heel cords. Can use orthotics such as AFOs. Surgery – Surgery can correct pes cavus, heel varus and hammer toes. Can do triple arthrodesis of the ankle and tendon transfers in the hands Evaluation at a multi-modal center specializing in neuromuscular disorders. These centers have OT, PT, physiatry and possibly vocational rehab to assist the patient in a complete evaluation and treatment plan. CA et al Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease. Muscle Nerve. 2006 Nov;34(5):586-94 Chetlin RD et al Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Muscle Nerve. 2004 Jul;30 (1):69-76 Folkers K et al Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10. Proc Natl Acad Sci USA. 1985;82(13):4513-6 Folkers K and Simonsen R. Two successful double-nl;ind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophy Acta. 1995 May 24;1271(1):281-6 Podratz, Jl et al Role of the extracellular matrix in myelinationb of peripheral nerve. Glia 2001, vol 35, n1, pp. 35-40 (23ref) Meyer zu Horate G et al Myelin disorders:causes and perspectives of Charcot-Marie-Tooth neuropathy. L Mol Neurosci. 2006;28(1):77-88 Pareyson D et al A multicenter, randomized, double-blind, placebo controlled trial of long-term ascorbic acid treatment in charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol (EudraCT no.;2006-000032-37). Pharmacol Res. 2006 Dec;54(6):436-41. Epub 2006 Sep 9 LL et al Acivated T cells in type I charcot-Marie-Tooth disease: evidence for immunologic heterogeneity. J Neuroimmnol. 1987 Nov;16(3):317-30 LL and FS Arachidonic fatty acid in red blood cell membranes, lymphocytes, and cultured skin fibroblasts of dominant Charcot-Maire-Tooth syndrome. J Neurol Sci. 1993 Dec 15;120(2):195-200 LL et al Circulating cytotoxic immune components in dominant Charcot-Marie-Tooth syndrome. J Clin immunol. 1993 Nov;13(6):389-96 Kobsar I et al Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J Neurosci Res. 2005 Sep 15;81(6):857-64 LL et al Dietary essential fatty acids, vitamin E and Charcot- Marie-Tooth disease. Neurology. 1986 Sep;36(9):1200-5 Dr. Sidney Kurn . 95 Montgomery Drive #126. Santa , California 95404 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 23, 2008 Report Share Posted February 23, 2008 Earlier this week, in message #46550,I posted the link http://integratedneurology.net/cmt.htm and information on vitamins and supplements suggested for CMT by Dr. Sidney Kurn. I was curious, so I contacted Dr. Kurn about his ideas and told him about my experience with vitamins and supplements, along with info about . Below is his response. ~ Gretchen " Good for you Gretchen - it takes work to heal - and you have done the work. Every one has different needs and one has to keep searching since our needs change over time. Your current formula seems very reasonable. Like the colloidal silica...thanks for contacting me. I passed your message on to a local CMT group " - Sidney Kurn MD Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2008 Report Share Posted February 24, 2008 Hi Gretchen, In your opinion, what would be the best time of the day to give each supplement to my twelve-year-old son? I am going to get everything from your list. I currently give him vitamin B12 after breakfast, along with Phosphatidylserire (which I buy at Whole Foods and was prescribed to my son by a neurologist in Germany). Then during dinner, I give him his multi-vitamin formulated for pre-teens. What about curcummin? http://www.ajhg.org/AJHG/abstract/S0002-9297(07)61342-1 His genetics specialist in Joe DiMaggio Children's Hospital recommended it to him. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2008 Report Share Posted February 24, 2008 Hi , I really can't say, but from my own experience, I have always taken the Vitamins and supplements in the morning, after breakfast. That is how I take E now. The only exception to this was in my teens when I took a liquid potassium supplement and the doc had it prescribedd twice a day, morning and afternoon. Perhaps your neurologist could give you better suggestions. As for the Curcumin, there is an amazing body of written research on it as a healer - perhaps your local health or supplement store can provide you with suggested amount for your son's age and weight. Gretchen Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 24, 2008 Report Share Posted February 24, 2008 Thank you, Gretchen... Will do Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.